Credit Suisse’s Entrada Therapeutics TRDA Stock Holding History

Credit Suisse’s Portfolio TRDA Stock Details TRDA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$227K	Buy
2023 Q4	$239K	Sell
2023 Q3	$260K	Sell
2023 Q2	$260K	Buy
2023 Q1	$180K	Buy
2022 Q4	$119K	Buy
2022 Q3	–	Sell
2022 Q2	$0	Buy